bioRxivBioinformaticsPreprint
Every Cure Knowledge Graph: A Unified Biomedical Knowledge Graph for Drug Repurposing
Piotr KaniewskiiD, Kathleen CarteriD, Daniel R. RhodesiD, En May LimiD, Jane LiiD, Jacques VergineiD, Nicolas MatentzogluiD, Kevin SchaperiD, Jason ReillyiD, Shilpa SundariD, Laurens VijnckiD, Elliott SharpiD, Nelson AlfonsoiD, Amy FordiD, Alexei StepanenkoiD, Charlie HempsteadiD, Pascal BrokmeieriD, Chris BizoniD, Alexander TropshaiD, Melissa Anne HaendeliD, David C. FajgenbaumiD, Lee LancashireiD
Abstract
Identifying causal connections between existing drugs and mechanistic profiles of diseases is a foundational step for effective drug repurposing. Although knowledge graphs (KGs) are highly suited for consolidating biomedical databases and tracking these connections, a single biomedical KG is constrained by its ingestion pipeline and knowledge sources. While different biomedical KGs could be complementary if combined, efforts to combine them into a unified and more comprehensive KG are hindered by lack of interoperability and poor provenance. To address those issues, we present EC-KG, a Biolink Model-compatible KG for computational drug repurposing. EC-KG is an interoperable, provenance-first KG which integrates RTX-KG2, ROBOKOP, and PrimeKG at the network-level, encapsulating over 7 million nodes and 81 million edges from 95 primary data sources. EC-KG has improved coverage of core biomedical entities such as drugs, targets, and diseases relevant to drug repurposing vs source graphs, and captures complex biomedical mechanisms within its topology. We demonstrate that the network unification in EC-KG leads to emergence of novel, mechanistically relevant pathways which are disconnected in the underlying constituent networks and show its applications in method development, benchmarking and predictive drug repurposing applications. EC-KG has already been successfully used in drug repurposing research to surface Botulinum Toxin A as a candidate to treat Major Depressive Disorder, as well as to validate repurposing of Lenalidomide and Dexamethasone for a subgroup of patients with Rosai-Dorfman Disease.
- research focus: drug response / drug discovery
- research focus: benchmarking
- research focus: database / resource
- approach: statistical model
- approach: benchmark study
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug Repurposing using Consilience of Knowledge Graph Completion Methods
Roger Tu, Meghamala Sinha, … Andrew I. Su·bioRxiv·May 12, 2023
- Leveraging Distributed Biomedical Knowledge Sources to Discover Novel Uses for Known Drugs
Finn Womack, Jason McClelland, David Koslicki·bioRxiv·Sep 12, 2019
- SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing
Karim S. Shalaby, Sathvik Guru Rao, … Vinay Srinivas Bharadhwaj·Bioinformatics AdvancesPeer-reviewed·Dec 26, 2024
- KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description
Chunyu Ma, Zhihan Zhou, … David Koslicki·GigaSciencePeer-reviewed·Dec 28, 2022
- CAREPath: Semantic Context-Aware Reasoning Paths with Mechanism-Augmented Embeddings for Drug Repurposing
Haerin Song, Dongmin Bang, … Sangseon Lee·Briefings in BioinformaticsPeer-reviewed·Aug 10, 2026
- Deep Learning-Based Drug Repurposing Using Knowledge Graph Embeddings and GraphRAG
Herbert George, Gowtham Baratam, DS Dhyaneesh·bioRxiv·Dec 10, 2025